Use of immune modulators in nonspecific therapy of bacterial infections
- 1 January 1992
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (1) , 1-5
- https://doi.org/10.1128/aac.36.1.1
Abstract
No abstract availableThis publication has 56 references indexed in Scilit:
- Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense in vitro, in animal models, and in humansDiagnostic Microbiology and Infectious Disease, 1990
- An Acquired Chemotactic Defect in Neutrophils from Patients Receiving Interleukin-2 ImmunotherapyNew England Journal of Medicine, 1990
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- Protective immunity induced by low-virulence Candida albicans: Cytokine production in the development of the anti-infectious stateCellular Immunology, 1989
- Protective effects of recombinant human tumour necrosis factor α and interferon γ against surgically simulated wound infection in miceBritish Journal of Surgery, 1989
- Novel neutrophil-stimulating peptidesImmunology Today, 1989
- Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.The Journal of Experimental Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- Lipid A, the active part of bacterial endotoxins in inducing serum colony stimulating activity and proliferation of splenic granulocyte/macrophage progenitor cellsJournal of Cellular Physiology, 1976